Get a real taste and understanding of the business and culture of one of the world's great research-based cellular and gene therapy discovery and development companies.
EXPLORE MORECreative Biolabs has a tradition of commitment. To achieve efficient execution and regulatory approval, we offer careful considerations of your program for the development of a cellular or gene therapy product – now and in the future.
EXPLORE MOREWe focus on unmet needs and develop novel cellular and gene drugs and solutions that offer significant benefits over existing options.
EXPLORE MORETo accelerate advanced breakthroughs of your projects, we offer broad range of platforms which enable our clients be free to tackle problems with cutting-edge technologies from different angles and in different methods.
EXPLORE MOREUse the resources in our library to help you understand your options and make critical decisions for your study. We offer oncolytic virus, CAR-T, and dendritic cell related documents, as well as newsletter. If you don’t find the answers you’re looking for, contact us for additional assistance.
EXPLORE MORE
With an international network of scientific experts in various areas of vaccine discovery, immunology, pathology and vaccine safety, efficacy, potency testing, Creative Biolabs provides vaccine in vivo assessment to our clients to ensure the appropriate in vivo studies are developed, performed and analyzed. We are dedicated to developing the most effective way to promote your vaccine project.
“Design, Assess and Optimize for Clinical Initiation”
Our scientific experts can provide our clients with the strategic guidance to develop and validate custom studies or testing, and offer high-quality laboratory services to ensure regulatory success. Our solutions include assay development, toxicological testing (especially immunogenicity), efficacy monitoring, project and data management, and shaping outcomes to meet your vaccine in vivo evaluation needs throughout the life cycle of vaccine development. We provide our clients with extensive expertise to implement the right solutions to ensure your vaccine candidate is safe and effective. For current in-house in vivo services, please visit the following modules. If you are interested in any other studies with specific requirements, please contact us for a customized solution.
Creative Biolabs is dedicated to establishing the most appropriate animal models for cancer vaccine development...
Creative Biolabs provides preclinical pharmacological services, scientifically considering the properties of a cancer vaccines and their predictive clinical use...
Our toxicology studies offer insights to safety data required for vaccine development to meet regulatory requirements in a GLP compliant environment...
Your cancer vaccine development requires a partner who understands your unique and complex demands. With over a decade in cancer therapy and immunology assay development and preclinical in vivo services, our scientific experts ensure:
to optimize your assay designs, ensure better outcomes and accelerate your project to regulatory approvals.
Our experienced and senior global project managers have rich knowledge of vaccine development to provide our clients with first-class quality systems to ensure excellent delivery. Combined with quality management systems, we ensure the integrity of sample products for superior quality data delivery and better results.
Creative Biolabs provides insights and expertise to ensure that the most appropriate assays or studies are developed to meet your drug development goals. We are committed to adopting high standards to increase the probability of your project success.
Please feel free to contact us to learn how we can help your projects.
For any technical issues or products/services related questions, please leave your contacts as below, and our team will contact you at earliest convenience to let you know how we can be involved in your projects.
Nanoparticle Tiny Tech for Programming T Cells: A novel technology to increase the efficiency and value of your CAR-T therapy project.
LEARN MORE
End-to-end CAR Hybrid TCR (CHyT)-T Cell Therapy Development Services: A novel solution to engineer T cell to be a promising cellular therapy with the complete TCR without HLA dependence.
LEARN MORE
TRAC-CAR-T Cell Development with CRISPR/Cas9 Technology: A novel technology to build more powerful CAR-T cells.
LEARN MORE
The latest newsletter to introduce the latest breaking information, our site updates, field and other scientific news, important events, and insights from industry leaders
LEARN MORE
